Brand dynamics

Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health

The Jiankang Yuan Public Welfare Volunteer Association has been officially established!

Time Posted:2019-03-27 11:22

On March 24th, the first public welfare activity of "Walking & Picking" was launched in Shenzhen at the headquarters of Health Yuan. The Health Yuan Public Welfare Volunteer Association was also officially established on this day.

Yu Xinguo, member of the Standing Committee of the Municipal Party Committee and Secretary of the Municipal Commission of Political and Legal Affairs, led a team to inspect Joincare Pharmaceutical Group Industry Co., Ltd

Time Posted:2019-03-27 11:12

On the morning of March 26, Yu Xinguo, member of the Standing Committee of the Municipal Party Committee and Secretary of the Political and Legal Affairs Committee, led a team to investigate the progress of the special campaign against gangsters and evil in Shenzhen's market sector. Accompanied by Hu Jiannong, Deputy Secretary of the Municipal Political and Legal Affairs Committee, and relevant officials from the Municipal Market Supervision Bureau and the Municipal Public Security Bureau, he visited the headquarters of Joincare Pharmaceutical Group Industry Co., Ltd. to supervise and investigate the company's implementation of the "Hundred-Day Action to Rectify Disorder in the Health Care Market" (hereinafter referred to as the "Hundred-Day Action") and the special campaign against gangsters and evil.

Mr. Zhu Baoguo, Chairman of Jiankangyuan Pharmaceutical Group: Protecting the environment, phasing out the use of Freon in aerosols

Time Posted:2019-03-26 11:45

Technological advancements have brought about abundant material resources for humanity, but they have also caused immeasurable harm to the Earth, one example being the depletion of the ozone layer. In 1987, the United Nations invited 26 member states to sign an environmental protection convention in Montreal, Canada, agreeing to reduce and eliminate the use of chlorofluorocarbons (CFCs). With the growing awareness of environmental protection, governments and enterprises have increased their investment in environmental protection, achieving positive results. However, due to some technical reasons, the replacement of CFCs in aerosols has not yet been fully completed. Based on a deep understanding of environmental protection, HealthGen Pharmaceuticals Group has organized experts, increased R&D investment, overcome difficulties, and taken action to promote the elimination of CFCs in aerosols. On the eve of the launch of new products, we call for the firm implementation of the Montreal Protocol to contribute to the protection of the Earth's ecological environment. Source: Daily Economic News

How to solve the problem of relapse into poverty due to illness? Health Yuan explores a long-term poverty alleviation approach in the health industry

Time Posted:2019-03-26 11:41

Decades of hard work, only to be set back to square one by illness. The fact that ordinary families are impoverished by illness, and impoverished families cannot afford medical care, has long been a major problem hindering China's poverty alleviation efforts.

22 scientific and technological achievements from Jiaozuo City won the 2018 Henan Provincial Science and Technology Progress Award

Time Posted:2019-03-02 14:08

Reporters recently learned from the city's science and technology bureau that 22 scientific and technological achievements in Jiaozuo City won the 2018 Henan Provincial Science and Technology Progress Award, including 10 second prizes and 12 third prizes.

Li Xi, Secretary of the Provincial Committee, inspects Lizhu

Time Posted:2019-02-19 14:22

On the morning of February 13, Li Xi, member of the Political Bureau of the CPC Central Committee and Secretary of the Guangdong Provincial Committee of the CPC, conducted a field research in Zhuhai to study and implement General Secretary Xi Jinping's important speeches and instructions on Guangdong, thoroughly implement the work deployment of the 6th Plenary Session of the 12th Guangdong Provincial Committee, and promote the construction of the Guangdong-Hong Kong-Macao Greater Bay Area. He engaged in in-depth exchanges with enterprise leaders and R&D personnel. Li Zhu was a key stop in Secretary Li Xi's Zhuhai inspection. Zhu Baoguo, Chairman of Li Zhu Group, and Tang Yanggang, President of Li Zhu Group, welcomed the provincial leaders to Li Zhu for inspection and research. At the Li Zhu exhibition hall, Li Zhu traditional Chinese medicine specimen museum, and Li Zhu Research Institute, Chairman Zhu Baoguo briefed Secretary Li Xi on Li Zhu's current business operations, R&D innovation achievements, and the effectiveness of its talent strategy combining local cultivation with external introduction. Secretary Li Xi exchanged views with overseas experts and scientists who grew up at Li Zhu in the company's laboratory, praising their courageous spirit of R&D innovation. During the Li Zhu research, Secretary Li Xi listened to Chairman Zhu Baoguo's introduction of the company while inquiring about issues of concern. He affirmed Li Zhu's R&D innovation achievements and business development achievements, encouraging Li Zhu to fully leverage its leading role in independent innovation, focus on overcoming key core technologies, continuously improve its core competitiveness, cultivate and introduce talents, and achieve breakthrough results in the biopharmaceutical field as soon as possible. Secretary Li Xi hopes that party committees and governments at all levels will increase their efforts to care for and support the development and growth of private enterprises, effectively help solve the difficulties encountered in their development, and help enterprises develop rapidly. Accompanying Secretary Li Xi on his inspection of Li Zhu were Zheng Yanxiong, member of the Standing Committee of the Provincial Committee and Secretary-General of the Provincial Committee; Guo Yonghang, Secretary of the Zhuhai Municipal Committee; Yao Yisheng, Mayor of Zhuhai; and Yang Huabing, Secretary of the Jinwan District Committee of Zhuhai.

A tuberculosis drug from a subsidiary of Healthy Yuan has been included in the WHO's recommended procurement list.

Time Posted:2019-02-19 14:12

On February 14, Jiankangyuan announced that its subsidiary, Lizhu Pharmaceutical Group Co., Ltd.'s wholly-owned subsidiary, Lizhu Pharmaceutical Factory, independently developed Kanamycin Injection, which passed the World Health Organization (WHO) PQ certification (prequalification), and was included in the WHO's recommended procurement list. This news was also released through an announcement by Lizhu Group. Kanamycin Injection, used in combination with other anti-tuberculosis drugs, is mainly used to treat various forms of tuberculosis caused by Mycobacterium tuberculosis. As of February 14, 2019, Lizhu Pharmaceutical Factory had invested approximately RMB 6.38 million in R&D for Kanamycin Injection. In 2017, the global sales of Kanamycin preparations totaled US\$61.151 million, an increase of 38.44% compared to 2016. Among them, the sales of Kanamycin Injection totaled US\$3.2426 million, an increase of 24.72% compared to 2016. Jiankangyuan and Lizhu Group stated that the WHO PQ certification of Kanamycin Injection has opened up channels for the international market sales of Kanamycin preparations, provided strong support for the company's further expansion into overseas markets, and laid a solid foundation for the international certification of subsequent high-end preparation products. Source: Beijing News

< 1...495051...55 >